有机药用辅料市场 - 全球行业规模、份额、趋势、机会和预测，按类型、功能、应用、地区和竞争细分，2020-2030 年

2024 年全球有机药用辅料市场价值为 103.5 亿美元，预计到 2030 年将达到 165 亿美元，复合年增长率为 8.06%。药用辅料是添加到药物配方中以增强其稳定性、生物利用度和整体性能的非活性物质。由于对有机和清洁标籤药品的需求不断增加，源自天然来源的有机药用辅料受到了广泛关注。

市场概况
预测期	2026-2030
2024 年市场规模	103.5 亿美元
2030 年市场规模	165亿美元
2025-2030 年复合年增长率	8.06%
成长最快的领域	口服製剂
最大的市场	北美洲

该市场成长的主要驱动力之一是消费者对药品中有机和天然成分的认识和偏好不断提高。随着人们越来越注重健康并担心合成添加剂的潜在副作用，人们开始明显转向有机赋形剂。这一趋势与更广泛意义上的清洁和永续医疗保健解决方案的发展趋势相一致，推动了对有机药用辅料的需求。

此外，全球各地的监管机构一直在提倡使用更安全、更环保的辅料，进一步推动有机替代品市场的发展。这些赋形剂通常来自植物材料，例如纤维素、淀粉和树胶，为药物配方提供了可持续且环保的选择。

此外，製药业持续的研究和开发努力，加上生物技术和奈米技术的进步，为创新有机辅料配方创造了机会。这些创新旨在解决药物输送、溶解度和生物利用度的特定挑战，为有机辅料在新型药物製剂开发中发挥关键作用打开了大门。

主要市场驱动因素

消费者对有机产品的偏好日益增加

主要市场挑战

有机原料供应有限且变动多端

主要市场趋势

消费者对清洁标示药品的需求不断增长

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第四章：全球有机药用辅料市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（油脂化学品、碳水化合物、石化产品；蛋白质、其他）
  • 依功能分类（黏合剂、涂层剂、着色剂、崩解剂、其他功能）
  • 依应用分类（口服製剂、外用製剂、肠外製剂、其他应用）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按功能
  • 按应用
  • 按地区

第五章：亚太有机药用辅料市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型
  • 按功能
  • 按应用
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲有机药用辅料市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美有机药用辅料市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第 8 章：南美洲有机药用辅料市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲有机药用辅料市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 12 章：全球有机药用辅料市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Organic Pharmaceutical Excipients Market was valued at USD 10.35 Billion in 2024 and is expected to reach USD 16.50 Billion in the forecast period with a CAGR of 8.06% through 2030. The Global Organic Pharmaceutical Excipients Market is a dynamic and rapidly evolving sector within the pharmaceutical industry, poised for substantial growth in the coming years. Pharmaceutical excipients are inactive substances that are added to drug formulations to enhance their stability, bioavailability, and overall performance. Organic pharmaceutical excipients, derived from natural sources, have gained significant attention due to the increasing demand for organic and clean-label pharmaceutical products.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 10.35 Billion
Market Size 2030	USD 16.50 Billion
CAGR 2025-2030	8.06%
Fastest Growing Segment	Oral Formulations
Largest Market	North America

One of the key drivers of this market's growth is the rising consumer awareness and preference for organic and natural ingredients in pharmaceuticals. As individuals become more health-conscious and concerned about the potential side effects of synthetic additives, there has been a notable shift towards organic excipients. This trend aligns with the broader movement towards clean and sustainable healthcare solutions, driving the demand for organic pharmaceutical excipients.

Additionally, regulatory bodies across the globe have been advocating for the use of safer and more environmentally friendly excipients, further propelling the market for organic alternatives. These excipients, often sourced from plant-based materials such as cellulose, starch, and gums, offer a sustainable and eco-friendly option for pharmaceutical formulation.

Furthermore, the pharmaceutical industry's ongoing research and development efforts, coupled with advancements in biotechnology and nanotechnology, have created opportunities for innovative organic excipient formulations. These innovations aim to address specific challenges in drug delivery, solubility, and bioavailability, opening doors for organic excipients to play a crucial role in the development of novel drug formulations.

Key Market Drivers

Increasing Consumer Preference for Organic Products

The increasing consumer preference for organic products is a significant driving force behind the growing global organic pharmaceutical excipients market. In recent years, there has been a discernible shift in consumer attitudes towards health and wellness, leading to a heightened demand for organic and natural alternatives in various aspects of life, including pharmaceuticals.

Consumers today are more health-conscious and discerning than ever before. They are increasingly concerned about the potential side effects and health risks associated with synthetic ingredients and additives in pharmaceutical products. This heightened awareness has led to a growing preference for clean-label medications formulated with organic pharmaceutical excipients. These organic excipients, often sourced from natural materials like cellulose, starch, and gums, are considered safer and more aligned with the principles of holistic health and well-being.

The desire for transparency and clean ingredients in pharmaceuticals has become a central factor in consumer choices. Organic excipients offer the assurance of a natural and sustainable approach to medication, which resonates with consumers seeking healthier alternatives. Furthermore, organic pharmaceutical excipients are generally free from allergens and contaminants, which makes them a safer choice for individuals with sensitivities or allergies. Regulatory bodies have also recognized the importance of organic excipients in pharmaceutical formulations, aligning their guidelines and recommendations with consumer preferences. This convergence of consumer demand and regulatory support has created a conducive environment for the growth of the global organic pharmaceutical excipients market..

In response to the increasing prevalence of GERD, the Global Organic Pharmaceutical Excipients Market has expanded to provide innovative and advanced diagnostic tools. These tools include pH monitoring systems, impedance-pH monitoring systems, and other cutting-edge devices designed to precisely assess and diagnose GERD. Additionally, the market has seen the development of patient-friendly, minimally invasive testing options, which encourage individuals to seek diagnosis and treatment.

Key Market Challenges

Limited Availability and Variability of Organic Raw Materials

The global organic pharmaceutical excipients market is experiencing robust growth, driven by the rising demand for natural and sustainable pharmaceutical products. Organic excipients, sourced from natural materials like plants and starches, are gaining popularity for their clean-label appeal and eco-friendly attributes. However, one of the key challenges hindering the growth of this market is the limited availability and variability of organic raw materials.

Organic excipients are primarily derived from natural sources, and their quality and availability are influenced by various factors, including climate, soil conditions, and agricultural practices. Unlike synthetic excipients, which can be manufactured with a high degree of precision and consistency, organic raw materials are subject to the vagaries of nature. This inherent variability can pose several challenges for the pharmaceutical industry.

The limited availability of organic raw materials can lead to supply chain disruptions. The production of organic excipients relies on a steady and sustainable supply of organic feedstock. When these raw materials are in short supply due to factors such as adverse weather conditions or fluctuations in crop yields, pharmaceutical manufacturers may face delays in production or increased costs as they seek alternative sources.

the variability in the quality and composition of organic raw materials can impact the consistency of organic excipients. Pharmaceutical formulations require precise and predictable properties to ensure the safety and efficacy of medications. Variability in excipient characteristics can make it challenging to achieve the desired drug formulation attributes, leading to concerns about product performance and patient safety.

Moreover, the variability of organic raw materials can also affect the cost of production. Pharmaceutical companies may need to invest in rigorous quality control processes to mitigate the impact of variations in organic excipients. This additional quality control can lead to increased production costs, potentially making organic excipients less competitive compared to their synthetic counterparts.

Key Market Trends

Rising Consumer Demand for Clean-Label Pharmaceuticals

The rising consumer demand for clean-label pharmaceuticals is a pivotal driver behind the burgeoning global organic pharmaceutical excipients market. In recent years, consumers have become increasingly health-conscious and discerning about the products they consume, including medications. This shift in consumer preferences towards clean-label pharmaceuticals, which are characterized by transparent ingredient lists containing natural and organic components, has created a substantial surge in demand for organic excipients.

Consumers are now more than ever concerned about the safety and efficacy of the medications they take, as well as the potential side effects of synthetic additives and artificial ingredients. They are actively seeking pharmaceutical products that align with their preference for natural and sustainable ingredients, and organic excipients fit the bill perfectly.

Organic excipients, sourced from natural materials like plant-based cellulose, starch, and gums, offer consumers a sense of transparency and assurance in their pharmaceuticals. These excipients are perceived as safer, cleaner, and more environmentally friendly than their synthetic counterparts. They resonate with consumers' desires for holistic health and well-being and cater to their demand for clean-label products free from synthetic and artificial additives.

The clean-label movement extends beyond the food and beverage industry, where it originated, and has made its way into pharmaceuticals. Consumers now prioritize pharmaceutical products that contain recognizable and natural ingredients, which has placed organic excipients in the spotlight.

Additionally, regulatory bodies have taken note of this consumer trend, encouraging pharmaceutical manufacturers to opt for safer and more environmentally friendly excipients in their formulations. The regulatory support for clean-label pharmaceuticals, which often includes organic excipients, further propels their market growth.

Key Market Players

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

Report Scope:

In this report, the Global Organic Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organic Pharmaceutical Excipients Market, By Type:

• Oleochemicals
• Carbohydrates
• Petrochemicals
• Protein
• Other

Organic Pharmaceutical Excipients Market, By Function:

• Binders
• Coating Agents
• Colorants
• Disintegrates
• Other Functions

Organic Pharmaceutical Excipients Market, By Application:

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Applications

Organic Pharmaceutical Excipients Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organic Pharmaceutical Excipients Market.

Available Customizations:

Global Organic Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Organic Pharmaceutical Excipients Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Oleochemicals, Carbohydrates, Petrochemicals; Protein, Other)
  • 4.2.2. By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions)
  • 4.2.3. By Application (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Function
  • 4.3.3. By Application
  • 4.3.4. By Region

5. Asia Pacific Organic Pharmaceutical Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Function
  • 5.2.3. By Application
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Organic Pharmaceutical Excipients Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Function
      • 5.3.1.2.3. By Application
  • 5.3.2. India Organic Pharmaceutical Excipients Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Function
      • 5.3.2.2.3. By Application
  • 5.3.3. Australia Organic Pharmaceutical Excipients Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Function
      • 5.3.3.2.3. By Application
  • 5.3.4. Japan Organic Pharmaceutical Excipients Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Function
      • 5.3.4.2.3. By Application
  • 5.3.5. South Korea Organic Pharmaceutical Excipients Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Function
      • 5.3.5.2.3. By Application

6. Europe Organic Pharmaceutical Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Function
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Organic Pharmaceutical Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Function
      • 6.3.1.2.3. By Application
  • 6.3.2. Germany Organic Pharmaceutical Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Function
      • 6.3.2.2.3. By Application
  • 6.3.3. Spain Organic Pharmaceutical Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Function
      • 6.3.3.2.3. By Application
  • 6.3.4. Italy Organic Pharmaceutical Excipients Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Function
      • 6.3.4.2.3. By Application
  • 6.3.5. United Kingdom Organic Pharmaceutical Excipients Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Function
      • 6.3.5.2.3. By Application

7. North America Organic Pharmaceutical Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Function
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Organic Pharmaceutical Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Function
      • 7.3.1.2.3. By Application
  • 7.3.2. Mexico Organic Pharmaceutical Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Function
      • 7.3.2.2.3. By Application
  • 7.3.3. Canada Organic Pharmaceutical Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Function
      • 7.3.3.2.3. By Application

8. South America Organic Pharmaceutical Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Function
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Organic Pharmaceutical Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Function
      • 8.3.1.2.3. By Application
  • 8.3.2. Argentina Organic Pharmaceutical Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Function
      • 8.3.2.2.3. By Application
  • 8.3.3. Colombia Organic Pharmaceutical Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Function
      • 8.3.3.2.3. By Application

9. Middle East and Africa Organic Pharmaceutical Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Function
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Organic Pharmaceutical Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Function
      • 9.3.1.2.3. By Application
  • 9.3.2. Saudi Arabia Organic Pharmaceutical Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Function
      • 9.3.2.2.3. By Application
  • 9.3.3. UAE Organic Pharmaceutical Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Function
      • 9.3.3.2.3. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Organic Pharmaceutical Excipients Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Roquette Freres SA
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. DuPont de Nemours Inc.
• 14.3. Ashland Inc.
• 14.4. BASF SE
• 14.5. Kerry Group plc
• 14.6. Evonik Industries AG
• 14.7. Croda International plc
• 14.8. The Lubrizol Corporation
• 14.9. Innophos Holdings Inc.
• 14.10. Wacker Chemie AG

15. Strategic Recommendations

16. About Us & Disclaimer